These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Lipoprotein binding and hypertriglyceridemia in chronic uremia. Samar RE; Moncrief JW; Decherd JF; Popovich RP Trans Am Soc Artif Intern Organs; 1975; 21():455-63. PubMed ID: 167492 [No Abstract] [Full Text] [Related]
8. Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesis. Cattran DC; Steiner G; Fenton SS; Wilson DR Trans Am Soc Artif Intern Organs; 1974; 20A():148-52. PubMed ID: 4450333 [No Abstract] [Full Text] [Related]
9. [Dyslipidemia and accelerated atherosclerosis in chronic uremia: a probably decreasing pathology, due to nutritional studies and better dietary guidelines]. Campanacci L; Guabnieri GF; Toigo G; Huber W; Legnani F; Moracchiello M; Tesio F; Raimondi A G Clin Med; 1978; 59(7-8):318-31. PubMed ID: 216602 [No Abstract] [Full Text] [Related]
10. [Changes in serum lipid and lipoprotein levels in patients with chronic uremia during hemodialysis treatment]. László A; Csalánosiné Németh M; Joó I; Kiss E; Havass Z; Szenohradszki P Orv Hetil; 1986 May; 127(19):1129-31. PubMed ID: 3714258 [No Abstract] [Full Text] [Related]
11. Apoprotein composition of plasma lipoproteins in uremic patients on hemodialysis. Staprans I; Felts JM; Zacherle B Clin Chim Acta; 1979 Apr; 93(1):135-43. PubMed ID: 219972 [No Abstract] [Full Text] [Related]
12. Lipoprotein profile in dialysis and transplant patients. Lau YK; Woo KT; Lim CH Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396 [No Abstract] [Full Text] [Related]
13. Presence of Apo B48, and relative Apo CII deficiency and Apo CIII enrichment in uremic very-low density lipoproteins. Atger V; Beyne P; Frommherz K; Roullet JB; Drüeke T Ann Biol Clin (Paris); 1989; 47(8):497-501. PubMed ID: 2690681 [TBL] [Abstract][Full Text] [Related]
14. Is there a treatment necessity for lipid disorders of uremic patients? Lacour B; Roullet JB; Beyne P; Drüeke T Blood Purif; 1985; 3(1-3):42-51. PubMed ID: 3938287 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal study on hyperlipidaemia and diet in RDT patients. Palmo A; Boggio-Bertinet D; Balzola F; Stratta P; Triolo G; Alloatti S; Bosticardo G; Giacchino F; Pagano GF; Levis F Minerva Nefrol; 1982; 29(1):29-35. PubMed ID: 7048140 [No Abstract] [Full Text] [Related]
16. Atherosclerosis in uremia: a longitudinal study. Bonomini V; Feletti C; Scolari MP; Stefoni S; Vangelista A Am J Clin Nutr; 1980 Jul; 33(7):1493-500. PubMed ID: 6994473 [TBL] [Abstract][Full Text] [Related]
17. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients. Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882 [TBL] [Abstract][Full Text] [Related]